Abstract

Antiviral effectors such as Natural Killer (NK) cells have impaired functions in chronic hepatitis B (CHB) patients. The molecular mechanism responsible for this dysfunction remains poorly characterized. We show that decreased cytokine production capacity of peripheral NK cells from CHB patients was associated with reduced expression of NKp30 and CD16, and defective mTOR pathway activity. Transcriptome analysis of patients NK cells revealed an enrichment for transcripts expressed in exhausted T cells suggesting that NK cell dysfunction and T cell exhaustion employ common mechanisms. In particular, the transcription factor TOX and several of its targets were over-expressed in NK cells of CHB patients. This signature was predicted to be dependent on the calcium-associated transcription factor NFAT. Stimulation of the calcium-dependent pathway recapitulated features of NK cells from CHB patients. Thus, deregulated calcium signalling could be a central event in both T cell exhaustion and NK cell dysfunction occurring during chronic infections.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE153946.

The following data sets were generated

Article and author information

Author details

  1. Marie Marotel

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Marine Villard

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Annabelle Drouillard

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Issam Tout

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Laurie Besson

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Omran Allatif

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marine Pujol

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Yamila Rocca

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Michelle Ainouze

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Guillaume Roblot

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Sébastien Viel

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5085-443X
  12. Melissa Gomez

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Veronique Loustaud

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sophie Alain

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  15. David Durantel

    Cancerology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Thierry Walzer

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    thierry.walzer@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0857-8179
  17. Uzma Hasan

    Immunology, Inserm, Lyon, France
    For correspondence
    uzma.hasan@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  18. Antoine Marçais

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    antoine.marcais@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3591-6268

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ22398)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ11169)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ19856)

  • Uzma Hasan

Agence Nationale de la Recherche (BaNK)

  • Antoine Marçais

Agence Nationale de la Recherche (SPHINKS)

  • Thierry Walzer

Association de Recherche sur le Cancer (Equipe labellisée)

  • Thierry Walzer

H2020 European Research Council (ERC-Stg 281025)

  • Thierry Walzer

La Ligue Nationale contre le Cancer (Graduate student fellowship)

  • Marie Marotel

La Ligue du Rhone (LNCC)

  • Uzma Hasan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Stipan Jonjic, University of Rijeka, Croatia

Ethics

Human subjects: All participants provided written informed consent in accordance with the procedure approved by the local ethics committee (Comité de Protection des Personnes, Centre Hospitalier Universitaire de Limoges, Limoges, France) and the Interventional research protocol involving human samples (Code promotor LiNKeB project: 87RI18-0021).

Version history

  1. Received: June 16, 2020
  2. Accepted: January 28, 2021
  3. Accepted Manuscript published: January 28, 2021 (version 1)
  4. Version of Record published: February 8, 2021 (version 2)

Copyright

© 2021, Marotel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,372
    views
  • 347
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marie Marotel
  2. Marine Villard
  3. Annabelle Drouillard
  4. Issam Tout
  5. Laurie Besson
  6. Omran Allatif
  7. Marine Pujol
  8. Yamila Rocca
  9. Michelle Ainouze
  10. Guillaume Roblot
  11. Sébastien Viel
  12. Melissa Gomez
  13. Veronique Loustaud
  14. Sophie Alain
  15. David Durantel
  16. Thierry Walzer
  17. Uzma Hasan
  18. Antoine Marçais
(2021)
Peripheral Natural Killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
eLife 10:e60095.
https://doi.org/10.7554/eLife.60095

Share this article

https://doi.org/10.7554/eLife.60095

Further reading

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.